Polish Radio: Drugs absorbed through the skin. A breakthrough in research?

– There are several routes by which drugs can penetrate through the skin. Starting from the least used, but still having great potential: sebaceous ducts and hair follicles which form a transfollicular route, leading directly into the bloodstream. Then we have a transdermal route, where an active substance goes through individual layers of cells. There is also […]

Read more

Biotts: an innovative form of anti-diabetic drug being developed in Wrocław

We are just witnessing an innovative form of anti-diabetic drug being developed in Wrocław. Polish researchers have received more than 11 million PLN from the “Fast Track” competition in the Smart Growth programme to study the drug penetration through the skin into the bloodstream and prepare a relevant therapy implementation. In the future, this innovative drug […]

Read more

Parkiet: Polish biotechnology is getting ready to jump

Parkiet: In the first months of 2020, the number of transactions carried out by PE and VC funds decreased. One of the few actual investments was that of Montis Capital in Biotts – a biotech company. – Biotts is an exception, rather than a rule in these circumstances, as there are virtually no major investments on the market. […]

Read more

HCC Online: Start-ups in medicine

Stay tuned. On June 8, our CEO, Paweł Biernat will discuss our unique transdermal carrier and other topics as part of the Health Challenges Congress – HCC Online: Start-ups in medicine (the session will start at 04.15 pm). It is already the fifth edition of the Congress with the main event and all accompanying events entirely held […]

Read more

Biotts is in business with Balanced Biotech – Polish technology is going the fight against breast cancer

We have signed a licencing agreement w Balanced Biotech – the American biotech company. Together they will create a revolutionary treatment for breast cancer. The licencing agreement between the companies is valued at several million USD. As of 2018 the market for breast-cancer treatments was valued at 13.4B USD – by 2021 that figure is […]

Read more

My company: Find answers to diseases (Biotts)

My Company: In the business of diagnostics and telemedicine, stakes are high. (…) Although Biotts, a company established in 2018, is already in possession of the product, the licence-selling process takes time, commitment, and global travel. The company’s flagship product: MTC-Y transdermal carrier is a system for delivering active substances into the body through the skin. Depending […]

Read more